UNIVERSIDADE NOVA DE LISBOA

The EU EVEREST project, coordinated by Prof. Breandán Kennedy, aims to standardize methods for isolating and characterizing extracellular vesicles, crucial for ultra-targeted therapies. Funded by the MSCA programme under Horizon Europe, the €1.3m project involves 21 institutions from 11 countries and will run for 48 months starting in January 2025. The consortium includes top academic and non-academic partners across Europe, focusing on improving treatments for complex diseases like cancer and cardiovascular conditions.